Detalhe da pesquisa
1.
The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.
Gynecol Oncol
; 167(2): 323-333, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150916
2.
Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives.
Gynecol Oncol
; 160(3): 844-850, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375990
3.
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer.
Gynecol Oncol
; 150(2): 274-281, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804638
4.
Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.
Gynecol Oncol
; 150(1): 127-135, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793804
5.
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Hum Mol Genet
; 24(20): 5955-64, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26231222
6.
Genetic predisposition to bevacizumab-induced hypertension.
Gynecol Oncol
; 147(3): 621-625, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969913
7.
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Hum Genet
; 135(7): 741-56, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27075448
8.
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
Mod Pathol
; 29(1): 60-6, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26564006
9.
Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.
Gynecol Oncol
; 141(2): 260-263, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26968641
10.
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.
Mol Cell Proteomics
; 13(7): 1690-704, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24719451
11.
Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.
Radiology
; 274(3): 742-51, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25383459
12.
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Cancer
; 119(3): 548-554, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22930283
13.
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.
Gynecol Oncol
; 128(3): 512-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23168173
14.
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.
Gynecol Oncol
; 128(2): 191-7, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23063761
15.
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Int J Gynecol Cancer
; 23(9): 1603-11, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172097
16.
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.
Gynecol Oncol
; 124(1): 59-62, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982046
17.
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Gynecol Oncol
; 124(1): 10-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917306
18.
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol
; 125(3): 621-4, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22446622
19.
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eur J Hum Genet
; 30(3): 349-362, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027648
20.
A microRNA survival signature (MiSS) for advanced ovarian cancer.
Gynecol Oncol
; 121(3): 444-50, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354599